Bensler’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bensler’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.9M	Buy	+54,546	New	+$14.2M	1.4%	22

Other funds holding FBT

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Csenge Advisory Group Clearwater, Florida $2.53B AUM 18.15% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Daymark Wealth Partners Cincinnati, Ohio $4.41B AUM 22.52% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return

Bensler's FBT Position: Q3 2026 in Review

Bensler opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026: 54,546 shares worth $14.9M. The stake represents 1.4% of the portfolio and ranks #22 among its holdings.

178 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Bensler held 54,546 shares of First Trust NYSE Arca Biotechnology Index Fund worth $14.9M as of Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Bensler position in Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 1.4% of Bensler's portfolio in Q3 2026, its #22 holding.
178 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Bensler's 13F filing for Q3 2026, filed 5 Nov 2026.